192 related articles for article (PubMed ID: 29521646)
1. Incorporating Advances in Molecular Pathology Into Brain Tumor Diagnostics.
Velázquez Vega JE; Brat DJ
Adv Anat Pathol; 2018 May; 25(3):143-171. PubMed ID: 29521646
[TBL] [Abstract][Full Text] [Related]
2. Biomarker-driven diagnosis of diffuse gliomas.
Appin CL; Brat DJ
Mol Aspects Med; 2015 Nov; 45():87-96. PubMed ID: 26004297
[TBL] [Abstract][Full Text] [Related]
3. Molecular genetics of gliomas.
Appin CL; Brat DJ
Cancer J; 2014; 20(1):66-72. PubMed ID: 24445767
[TBL] [Abstract][Full Text] [Related]
4. Molecular pathways in gliomagenesis and their relevance to neuropathologic diagnosis.
Appin CL; Brat DJ
Adv Anat Pathol; 2015 Jan; 22(1):50-8. PubMed ID: 25461780
[TBL] [Abstract][Full Text] [Related]
5. Molecular Testing of Brain Tumor.
Park SH; Won J; Kim SI; Lee Y; Park CK; Kim SK; Choi SH
J Pathol Transl Med; 2017 May; 51(3):205-223. PubMed ID: 28535583
[TBL] [Abstract][Full Text] [Related]
6. TERT promoter wild-type glioblastomas show distinct clinical features and frequent PI3K pathway mutations.
Williams EA; Miller JJ; Tummala SS; Penson T; Iafrate AJ; Juratli TA; Cahill DP
Acta Neuropathol Commun; 2018 Oct; 6(1):106. PubMed ID: 30333046
[TBL] [Abstract][Full Text] [Related]
7. Additional genetic alterations in BRAF-mutant gliomas correlate with histologic diagnoses.
Dono A; Vu J; Anapolsky M; Hines G; Takayasu T; Yan Y; Tandon N; Zhu JJ; Bhattacharjee MB; Esquenazi Y; Ballester LY
J Neurooncol; 2020 Sep; 149(3):463-472. PubMed ID: 33009979
[TBL] [Abstract][Full Text] [Related]
8. Molecular diagnostics of CNS embryonal tumors.
Pfister SM; Korshunov A; Kool M; Hasselblatt M; Eberhart C; Taylor MD
Acta Neuropathol; 2010 Nov; 120(5):553-66. PubMed ID: 20882288
[TBL] [Abstract][Full Text] [Related]
9. Impending Impact of Molecular Pathology on Classifying Adult Diffuse Gliomas.
Macaulay RJ
Cancer Control; 2015 Apr; 22(2):200-5. PubMed ID: 26068765
[TBL] [Abstract][Full Text] [Related]
10. Molecular classification of adult gliomas: recent advances and future perspectives.
Barritault M; Meyronet D; Ducray F
Curr Opin Oncol; 2018 Nov; 30(6):375-382. PubMed ID: 30148717
[TBL] [Abstract][Full Text] [Related]
11. Further understanding of the pathology of glioma: implications for the clinic.
Camelo-Piragua S; Kesari S
Expert Rev Neurother; 2016 Sep; 16(9):1055-65. PubMed ID: 27228211
[TBL] [Abstract][Full Text] [Related]
12. Diffusely infiltrating astrocytomas: pathology, molecular mechanisms and markers.
Ichimura K; Narita Y; Hawkins CE
Acta Neuropathol; 2015 Jun; 129(6):789-808. PubMed ID: 25975377
[TBL] [Abstract][Full Text] [Related]
13. Molecular background of oligodendroglioma: 1p/19q, IDH, TERT, CIC and FUBP1.
Cahill DP; Louis DN; Cairncross JG
CNS Oncol; 2015; 4(5):287-94. PubMed ID: 26545048
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation signatures for 2016 WHO classification subtypes of diffuse gliomas.
Paul Y; Mondal B; Patil V; Somasundaram K
Clin Epigenetics; 2017; 9():32. PubMed ID: 28392842
[TBL] [Abstract][Full Text] [Related]
15. Glioma biology and molecular markers.
Cohen AL; Colman H
Cancer Treat Res; 2015; 163():15-30. PubMed ID: 25468223
[TBL] [Abstract][Full Text] [Related]
16. Recent Advances on the Molecular Pathology of Glial Neoplasms in Children and Adults.
Rodriguez FJ; Vizcaino MA; Lin MT
J Mol Diagn; 2016 Sep; 18(5):620-634. PubMed ID: 27444975
[TBL] [Abstract][Full Text] [Related]
17. Molecular classification defines 4 prognostically distinct glioma groups irrespective of diagnosis and grade.
Mur P; Mollejo M; Hernández-Iglesias T; de Lope ÁR; Castresana JS; García JF; Fiaño C; Ribalta T; Rey JA; Meléndez B
J Neuropathol Exp Neurol; 2015 Mar; 74(3):241-9. PubMed ID: 25668564
[TBL] [Abstract][Full Text] [Related]
18. Characterization of gliomas: from morphology to molecules.
Ferris SP; Hofmann JW; Solomon DA; Perry A
Virchows Arch; 2017 Aug; 471(2):257-269. PubMed ID: 28674742
[TBL] [Abstract][Full Text] [Related]
19. PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.
Draaisma K; Wijnenga MM; Weenink B; Gao Y; Smid M; Robe P; van den Bent MJ; French PJ
Acta Neuropathol Commun; 2015 Dec; 3():88. PubMed ID: 26699864
[TBL] [Abstract][Full Text] [Related]
20. Applications of molecular neuro-oncology - a review of diffuse glioma integrated diagnosis and emerging molecular entities.
Wood MD; Halfpenny AM; Moore SR
Diagn Pathol; 2019 Apr; 14(1):29. PubMed ID: 30967140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
